🇺🇸 FDA
Patent

US 10029080

Method for delivering exenatide into a lumen of the intestinal tract using a swallowable drug delivery device

granted A61KA61K31/155A61K38/26

Quick answer

US patent 10029080 (Method for delivering exenatide into a lumen of the intestinal tract using a swallowable drug delivery device) held by Rani Therapeutics, LLC expires Mon Jul 19 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Rani Therapeutics, LLC
Grant date
Tue Jul 24 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 19 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/155, A61K38/26, A61K38/28, A61K45/06